Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07661095

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Cooperman Barnabas Medical Center, Livingston
Monmouth Medical Center, Long Branch
以及另外 6 项

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06317649

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Cooper Hospital University Medical Center, Camden
Cooperman Barnabas Medical Center, Livingston
以及另外 7 项

招募中2 期

18 至 59 岁 · 所有性别 · 更新于 2026年9月22日 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Hackensack University Medical Center, Hackensack
Morristown Medical Center, Morristown
Jersey Shore Medical Center, Neptune City
以及另外 4 项

招募中3 期

6 Months – 21 Years · 所有性别 · 更新于 2026年9月17日 · NCT04293562

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

John Theurer Cancer Center at Hackensack UMC, Hackensack

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月16日 · NCT06824168

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Atlantic Health, Morristown

招募中1/2 期

12 岁及以上 · 所有性别 · 更新于 2026年9月3日 · NCT04588922

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Englewood Hospital and Medical Center, Englewood
CentraState Medical Center, Freehold
Hackettstown Medical Center, Hackettstown
以及另外 7 项

招募中观察性研究欢迎健康志愿者

40 至 75 岁 · 所有性别 · 更新于 2026年9月2日 · NCT05334069

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Hackensack University Medical Center, Hackensack
Morristown Medical Center, Morristown
Jersey Shore Medical Center, Neptune City
以及另外 3 项

招募中1/2 期

22 岁及以下 · 所有性别 · 更新于 2026年8月25日 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Hackensack University Medical Center, HMH, Hackensack
Morristown Medical Center, Morristown

招募中3 期

29 Days – 21 Years · 所有性别 · 更新于 2026年8月24日 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年8月20日 · NCT06001788

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Rutgers Biomedical and Health Sciences, New Brunswick

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年8月20日 · NCT07007312

A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)

MDA at Cooper University Health Care, Camden

招募中早期 I 期

18 岁及以上 · 所有性别 · 更新于 2026年8月18日 · NCT07771803

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Atlantic Health, Morristown

招募中2/3 期

18 至 80 岁 · 所有性别 · 更新于 2026年8月5日 · NCT06788756

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

招募中2 期

60 岁及以上 · 所有性别 · 更新于 2026年7月17日 · NCT07392242

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年7月7日 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Hackensack University Medical Center, Hackensack
Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick

招募中观察性研究

所有年龄段 · 所有性别 · 更新于 2026年7月6日 · NCT01351545

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

招募中1 期

1 岁及以上 · 所有性别 · 更新于 2026年6月22日 · NCT06017258

A Study of Revumenib and Mezigdomide in People With Leukemia

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

招募中1/2 期

12 岁及以上 · 所有性别 · 更新于 2026年6月22日 · NCT07356154

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年6月22日 · NCT05756777

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

招募中1 期

18 至 70 岁 · 所有性别 · 更新于 2026年6月17日 · NCT07011004

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

John Theurer Cancer Center / Hackensack University, Hackensack

招募中2/3 期

18 岁及以上 · 所有性别 · 更新于 2026年4月30日 · NCT04256317

Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年4月8日 · NCT06419634

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Atlantic Health, Morristown
Rutgers Cancer Institute of New Jersey, New Brunswick

招募中1/2 期

12 岁及以上 · 所有性别 · 更新于 2026年3月24日 · NCT04988555

Phase IB/II of CPX-351 for Relapse Prevention in AML

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年3月23日 · NCT04990102

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Hackensack University Medical Center, Hackensack
Rutgers Cancer Institute, New Brunswick

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年3月13日 · NCT05735184

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年3月10日 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年2月24日 · NCT06773208

数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。

新泽西州 的 急性髓系白血病 临床试验

新泽西州 的城市

新泽西州的急性髓系白血病临床试验

新泽西州的城市